BIAF down 32.2% on Sep 9 2026 (dilution risk)
BIAF-32.2%on Wed Sep 9 2026
bioAffinity Technologies, Inc. Common Stock was down 32.2% on the day at $10.36, ranked #3 on 6.1× its usual five-minute volume, when TapeRank recorded this drop at 08:02 ET during the pre-market session.
WHAT THE ROW LOOKED LIKE
LAST10.36
DAY▼ 32.2%
5 MIN▲ 9.54%
5M RVOL6.1×
5M $VOL$546K
FLOAT*592K
RANK#3
SESSIONPRE-MARKET
* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
AI VERDICT
DILUTION RISKCONFIDENCE4/5
BIAF is down nearly 40% premarket following a 424B3 prospectus supplement that registers resale shares tied to an August 2026 private placement, effectively confirming a large overhang of freely tradable stock. The filing itself contains no new operational or business catalyst, only disclosure of financing mechanics and selling stockholders.
WHYA resale registration from a prior private placement does not typically justify a 39% single-day decline, pointing to dilution-driven selling pressure far outsized relative to the administrative nature of the filing.
ANALYZED 07:39 ET · 22 MIN AGO · ANTHROPIC/CLAUDE-SONNET-5
FILINGS · 24H BEFORE THE MOVE
- TUE 16:30 ET424B3 — Prospectus supplementSEC 424B3
SESSION LEVELS AT CAPTURE
VWAP9.42
HOD10.63
LOD8.36
OR HIGH—
OR LOW—
PREV CLOSE15.27
PM HIGH10.21
PM LOW8.59
GAP▼ 30.39%
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO